Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice

Hyaluronidases are groups of enzymes that degrade hyaluronic acid (HA). To stop enzymatic hydrolysis we modified testicular hyaluronidase (HYAL) by activated polyethylene oxide with the help of electron-beam synthesis. As a result we received pegylated hyaluronidase (pegHYAL). Spiperone is a selecti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-04, Vol.10 (4), p.e0125065
Hauptverfasser: Skurikhin, Evgenii Germanovich, Pershina, Olga Victorovna, Reztsova, Alena Mikhaylovna, Ermakova, Natalia Nikolaevna, Khmelevskaya, Ekaterina Sergeevna, Krupin, Vycheslav Andreevich, Stepanova, Inna Ernestovna, Artamonov, Andrew Vladimirovich, Bekarev, Andrew Alexandrovich, Madonov, Pavel Gennadjevich, Dygai, Alexander Mikhaylovich
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page e0125065
container_title PloS one
container_volume 10
creator Skurikhin, Evgenii Germanovich
Pershina, Olga Victorovna
Reztsova, Alena Mikhaylovna
Ermakova, Natalia Nikolaevna
Khmelevskaya, Ekaterina Sergeevna
Krupin, Vycheslav Andreevich
Stepanova, Inna Ernestovna
Artamonov, Andrew Vladimirovich
Bekarev, Andrew Alexandrovich
Madonov, Pavel Gennadjevich
Dygai, Alexander Mikhaylovich
description Hyaluronidases are groups of enzymes that degrade hyaluronic acid (HA). To stop enzymatic hydrolysis we modified testicular hyaluronidase (HYAL) by activated polyethylene oxide with the help of electron-beam synthesis. As a result we received pegylated hyaluronidase (pegHYAL). Spiperone is a selective D2 dopamine receptor antagonist. It was demonstrated on the model of a single bleomycin damage of alveolar epithelium that during the inflammatory phase monotherapy by pegHYAL or spiperone reduced the populations of hematopoietic stem /progenitor cells in the lung parenchyma. PegHYAL also reduced the levels of transforming growth factor (TGF)-β, interleukin (IL)-1β, tumor necrosis factor (TNF)-α in the serum and lungs, while spiperone reduced the level of the serum IL-1β. Polytherapy by spiperone and pegHYAL caused the increase of the quantity of hematopoietic stem/ progenitor cells in the lungs. Such an influx of blood cell precursors was observed on the background of considerable fall level of TGF-β and the increase level of TNF-α in the serum and lungs. These results show pegHYAL reduced the bleomycin-induced fibrosis reaction (production and accumulation of collagen) in the lung parenchyma. This effect was observed at a single and repetitive bleomycin damage of alveolar epithelium, the antifibrotic activity of pegHYAL surpassing the activity of testicular HYAL. The antifibrotic effect of pegHYAL is enhanced by an additional instillation of spiperone. Therapy by pegHYAL causes the flow of CD31‒ CD34‒ CD45‒ CD44+ CD73+ CD90+ CD106+-cells into the fibrous lungs. These cells are incapable of differentiating into fibroblast cells. Spiperone instillation separately or together with pegHYAL reduced the MSC-like cells considerably. These data enable us to assume, that pegHYAL is a new and promising instrument both for preventive and therapy of toxic pneumofibrosis. The blockage of D2 dopamine receptors with the following change of hyaluronan matrix can be considered as a new strategy in treatment of pneumofibrosis.
doi_str_mv 10.1371/journal.pone.0125065
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1677376614</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A419036039</galeid><doaj_id>oai_doaj_org_article_2de52e867ebe46538cc1bffb693cb2ea</doaj_id><sourcerecordid>A419036039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-b7f0751c394c4547daf76a9598983d80f1381201e4299dc362d226287270651e3</originalsourceid><addsrcrecordid>eNqNkl2L1DAYhYso7rr6D0QLguDFjPlok-ZGWBY_BlYW_LoNafK2k6FNukkrzr8343SXKShIL1LePOcknJwse47RGlOO3-78FJzq1oN3sEaYlIiVD7JzLChZMYLow5P_s-xJjDuESlox9jg7I6UgnGF8nt1-9mbq1Gi9y32T1x34fq-tW1lnJg0m7ybX5o2tg4825vU-H6DdJ0Ha2u5VNwXvrFERcuVMbvygeusgD6BhGH1I01G1CYljbl3eWw1Ps0eN6iI8m9eL7PuH99-uPq2ubz5uri6vV5oJMq5q3iBeYk1FoYuy4EY1nClRikpU1FSowbTCBGEoiBBGU0YMIYxUnPAUBAZ6kb08-g6dj3JOK0rMOKecMVwkYnMkjFc7OQTbq7CXXln5Z-BDK1UYre5AEgMlgYpxqKFgKUatcd00NRNU1wRU8no3nzbVPRgNbgyqW5gud5zdytb_lEWBS0FZMng1GwR_O0Ec_3HlmWpVupV1jU9murdRy8sCC0QZoiJR679Q6TOQXiD1pbFpvhC8WQgSM8KvsVVTjHLz9cv_szc_luzrE3YLqhu30XfToW5xCRZHUKeexQDNfXIYyUPd79KQh7rLue5J9uI09XvRXb_pb5vA-4Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1677376614</pqid></control><display><type>article</type><title>Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Skurikhin, Evgenii Germanovich ; Pershina, Olga Victorovna ; Reztsova, Alena Mikhaylovna ; Ermakova, Natalia Nikolaevna ; Khmelevskaya, Ekaterina Sergeevna ; Krupin, Vycheslav Andreevich ; Stepanova, Inna Ernestovna ; Artamonov, Andrew Vladimirovich ; Bekarev, Andrew Alexandrovich ; Madonov, Pavel Gennadjevich ; Dygai, Alexander Mikhaylovich</creator><contributor>Shi, Wei</contributor><creatorcontrib>Skurikhin, Evgenii Germanovich ; Pershina, Olga Victorovna ; Reztsova, Alena Mikhaylovna ; Ermakova, Natalia Nikolaevna ; Khmelevskaya, Ekaterina Sergeevna ; Krupin, Vycheslav Andreevich ; Stepanova, Inna Ernestovna ; Artamonov, Andrew Vladimirovich ; Bekarev, Andrew Alexandrovich ; Madonov, Pavel Gennadjevich ; Dygai, Alexander Mikhaylovich ; Shi, Wei</creatorcontrib><description>Hyaluronidases are groups of enzymes that degrade hyaluronic acid (HA). To stop enzymatic hydrolysis we modified testicular hyaluronidase (HYAL) by activated polyethylene oxide with the help of electron-beam synthesis. As a result we received pegylated hyaluronidase (pegHYAL). Spiperone is a selective D2 dopamine receptor antagonist. It was demonstrated on the model of a single bleomycin damage of alveolar epithelium that during the inflammatory phase monotherapy by pegHYAL or spiperone reduced the populations of hematopoietic stem /progenitor cells in the lung parenchyma. PegHYAL also reduced the levels of transforming growth factor (TGF)-β, interleukin (IL)-1β, tumor necrosis factor (TNF)-α in the serum and lungs, while spiperone reduced the level of the serum IL-1β. Polytherapy by spiperone and pegHYAL caused the increase of the quantity of hematopoietic stem/ progenitor cells in the lungs. Such an influx of blood cell precursors was observed on the background of considerable fall level of TGF-β and the increase level of TNF-α in the serum and lungs. These results show pegHYAL reduced the bleomycin-induced fibrosis reaction (production and accumulation of collagen) in the lung parenchyma. This effect was observed at a single and repetitive bleomycin damage of alveolar epithelium, the antifibrotic activity of pegHYAL surpassing the activity of testicular HYAL. The antifibrotic effect of pegHYAL is enhanced by an additional instillation of spiperone. Therapy by pegHYAL causes the flow of CD31‒ CD34‒ CD45‒ CD44+ CD73+ CD90+ CD106+-cells into the fibrous lungs. These cells are incapable of differentiating into fibroblast cells. Spiperone instillation separately or together with pegHYAL reduced the MSC-like cells considerably. These data enable us to assume, that pegHYAL is a new and promising instrument both for preventive and therapy of toxic pneumofibrosis. The blockage of D2 dopamine receptors with the following change of hyaluronan matrix can be considered as a new strategy in treatment of pneumofibrosis.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0125065</identifier><identifier>PMID: 25927611</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Alveoli ; Analysis ; Animals ; Bleomycin ; Bleomycin - toxicity ; Blockage ; Blood cells ; Bone morphogenetic proteins ; CD34 antigen ; CD44 antigen ; CD45 antigen ; CD73 antigen ; CD90 antigen ; Cells (biology) ; Collagen ; Dopamine ; Dopamine Antagonists - therapeutic use ; Dopamine D2 receptors ; Dopamine receptors ; Electron beams ; Enzyme-Linked Immunosorbent Assay ; Enzymes ; Epithelium ; Fibrosis ; Flow Cytometry ; Hematopoietic stem cells ; Hyaluronic acid ; Hyaluronoglucosaminidase - chemistry ; Hyaluronoglucosaminidase - therapeutic use ; IL-1β ; Inflammation ; Interleukins ; Lungs ; Male ; Mice ; Mice, Inbred C57BL ; Parenchyma ; Phenols (Class of compounds) ; Polyethylene ; Polyethylene oxide ; Polyethylenes ; Pulmonary Fibrosis - chemically induced ; Pulmonary Fibrosis - drug therapy ; Receptors ; Spiperone ; Spiperone - therapeutic use ; Testes ; Therapy ; Transforming growth factor ; Transforming growth factors ; Tumor necrosis factor ; Tumor necrosis factor-α</subject><ispartof>PloS one, 2015-04, Vol.10 (4), p.e0125065</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Skurikhin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Skurikhin et al 2015 Skurikhin et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-b7f0751c394c4547daf76a9598983d80f1381201e4299dc362d226287270651e3</citedby><cites>FETCH-LOGICAL-c692t-b7f0751c394c4547daf76a9598983d80f1381201e4299dc362d226287270651e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415936/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415936/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2929,23871,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25927611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Shi, Wei</contributor><creatorcontrib>Skurikhin, Evgenii Germanovich</creatorcontrib><creatorcontrib>Pershina, Olga Victorovna</creatorcontrib><creatorcontrib>Reztsova, Alena Mikhaylovna</creatorcontrib><creatorcontrib>Ermakova, Natalia Nikolaevna</creatorcontrib><creatorcontrib>Khmelevskaya, Ekaterina Sergeevna</creatorcontrib><creatorcontrib>Krupin, Vycheslav Andreevich</creatorcontrib><creatorcontrib>Stepanova, Inna Ernestovna</creatorcontrib><creatorcontrib>Artamonov, Andrew Vladimirovich</creatorcontrib><creatorcontrib>Bekarev, Andrew Alexandrovich</creatorcontrib><creatorcontrib>Madonov, Pavel Gennadjevich</creatorcontrib><creatorcontrib>Dygai, Alexander Mikhaylovich</creatorcontrib><title>Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Hyaluronidases are groups of enzymes that degrade hyaluronic acid (HA). To stop enzymatic hydrolysis we modified testicular hyaluronidase (HYAL) by activated polyethylene oxide with the help of electron-beam synthesis. As a result we received pegylated hyaluronidase (pegHYAL). Spiperone is a selective D2 dopamine receptor antagonist. It was demonstrated on the model of a single bleomycin damage of alveolar epithelium that during the inflammatory phase monotherapy by pegHYAL or spiperone reduced the populations of hematopoietic stem /progenitor cells in the lung parenchyma. PegHYAL also reduced the levels of transforming growth factor (TGF)-β, interleukin (IL)-1β, tumor necrosis factor (TNF)-α in the serum and lungs, while spiperone reduced the level of the serum IL-1β. Polytherapy by spiperone and pegHYAL caused the increase of the quantity of hematopoietic stem/ progenitor cells in the lungs. Such an influx of blood cell precursors was observed on the background of considerable fall level of TGF-β and the increase level of TNF-α in the serum and lungs. These results show pegHYAL reduced the bleomycin-induced fibrosis reaction (production and accumulation of collagen) in the lung parenchyma. This effect was observed at a single and repetitive bleomycin damage of alveolar epithelium, the antifibrotic activity of pegHYAL surpassing the activity of testicular HYAL. The antifibrotic effect of pegHYAL is enhanced by an additional instillation of spiperone. Therapy by pegHYAL causes the flow of CD31‒ CD34‒ CD45‒ CD44+ CD73+ CD90+ CD106+-cells into the fibrous lungs. These cells are incapable of differentiating into fibroblast cells. Spiperone instillation separately or together with pegHYAL reduced the MSC-like cells considerably. These data enable us to assume, that pegHYAL is a new and promising instrument both for preventive and therapy of toxic pneumofibrosis. The blockage of D2 dopamine receptors with the following change of hyaluronan matrix can be considered as a new strategy in treatment of pneumofibrosis.</description><subject>Alveoli</subject><subject>Analysis</subject><subject>Animals</subject><subject>Bleomycin</subject><subject>Bleomycin - toxicity</subject><subject>Blockage</subject><subject>Blood cells</subject><subject>Bone morphogenetic proteins</subject><subject>CD34 antigen</subject><subject>CD44 antigen</subject><subject>CD45 antigen</subject><subject>CD73 antigen</subject><subject>CD90 antigen</subject><subject>Cells (biology)</subject><subject>Collagen</subject><subject>Dopamine</subject><subject>Dopamine Antagonists - therapeutic use</subject><subject>Dopamine D2 receptors</subject><subject>Dopamine receptors</subject><subject>Electron beams</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Enzymes</subject><subject>Epithelium</subject><subject>Fibrosis</subject><subject>Flow Cytometry</subject><subject>Hematopoietic stem cells</subject><subject>Hyaluronic acid</subject><subject>Hyaluronoglucosaminidase - chemistry</subject><subject>Hyaluronoglucosaminidase - therapeutic use</subject><subject>IL-1β</subject><subject>Inflammation</subject><subject>Interleukins</subject><subject>Lungs</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Parenchyma</subject><subject>Phenols (Class of compounds)</subject><subject>Polyethylene</subject><subject>Polyethylene oxide</subject><subject>Polyethylenes</subject><subject>Pulmonary Fibrosis - chemically induced</subject><subject>Pulmonary Fibrosis - drug therapy</subject><subject>Receptors</subject><subject>Spiperone</subject><subject>Spiperone - therapeutic use</subject><subject>Testes</subject><subject>Therapy</subject><subject>Transforming growth factor</subject><subject>Transforming growth factors</subject><subject>Tumor necrosis factor</subject><subject>Tumor necrosis factor-α</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl2L1DAYhYso7rr6D0QLguDFjPlok-ZGWBY_BlYW_LoNafK2k6FNukkrzr8343SXKShIL1LePOcknJwse47RGlOO3-78FJzq1oN3sEaYlIiVD7JzLChZMYLow5P_s-xJjDuESlox9jg7I6UgnGF8nt1-9mbq1Gi9y32T1x34fq-tW1lnJg0m7ybX5o2tg4825vU-H6DdJ0Ha2u5VNwXvrFERcuVMbvygeusgD6BhGH1I01G1CYljbl3eWw1Ps0eN6iI8m9eL7PuH99-uPq2ubz5uri6vV5oJMq5q3iBeYk1FoYuy4EY1nClRikpU1FSowbTCBGEoiBBGU0YMIYxUnPAUBAZ6kb08-g6dj3JOK0rMOKecMVwkYnMkjFc7OQTbq7CXXln5Z-BDK1UYre5AEgMlgYpxqKFgKUatcd00NRNU1wRU8no3nzbVPRgNbgyqW5gud5zdytb_lEWBS0FZMng1GwR_O0Ec_3HlmWpVupV1jU9murdRy8sCC0QZoiJR679Q6TOQXiD1pbFpvhC8WQgSM8KvsVVTjHLz9cv_szc_luzrE3YLqhu30XfToW5xCRZHUKeexQDNfXIYyUPd79KQh7rLue5J9uI09XvRXb_pb5vA-4Q</recordid><startdate>20150430</startdate><enddate>20150430</enddate><creator>Skurikhin, Evgenii Germanovich</creator><creator>Pershina, Olga Victorovna</creator><creator>Reztsova, Alena Mikhaylovna</creator><creator>Ermakova, Natalia Nikolaevna</creator><creator>Khmelevskaya, Ekaterina Sergeevna</creator><creator>Krupin, Vycheslav Andreevich</creator><creator>Stepanova, Inna Ernestovna</creator><creator>Artamonov, Andrew Vladimirovich</creator><creator>Bekarev, Andrew Alexandrovich</creator><creator>Madonov, Pavel Gennadjevich</creator><creator>Dygai, Alexander Mikhaylovich</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150430</creationdate><title>Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice</title><author>Skurikhin, Evgenii Germanovich ; Pershina, Olga Victorovna ; Reztsova, Alena Mikhaylovna ; Ermakova, Natalia Nikolaevna ; Khmelevskaya, Ekaterina Sergeevna ; Krupin, Vycheslav Andreevich ; Stepanova, Inna Ernestovna ; Artamonov, Andrew Vladimirovich ; Bekarev, Andrew Alexandrovich ; Madonov, Pavel Gennadjevich ; Dygai, Alexander Mikhaylovich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-b7f0751c394c4547daf76a9598983d80f1381201e4299dc362d226287270651e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Alveoli</topic><topic>Analysis</topic><topic>Animals</topic><topic>Bleomycin</topic><topic>Bleomycin - toxicity</topic><topic>Blockage</topic><topic>Blood cells</topic><topic>Bone morphogenetic proteins</topic><topic>CD34 antigen</topic><topic>CD44 antigen</topic><topic>CD45 antigen</topic><topic>CD73 antigen</topic><topic>CD90 antigen</topic><topic>Cells (biology)</topic><topic>Collagen</topic><topic>Dopamine</topic><topic>Dopamine Antagonists - therapeutic use</topic><topic>Dopamine D2 receptors</topic><topic>Dopamine receptors</topic><topic>Electron beams</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Enzymes</topic><topic>Epithelium</topic><topic>Fibrosis</topic><topic>Flow Cytometry</topic><topic>Hematopoietic stem cells</topic><topic>Hyaluronic acid</topic><topic>Hyaluronoglucosaminidase - chemistry</topic><topic>Hyaluronoglucosaminidase - therapeutic use</topic><topic>IL-1β</topic><topic>Inflammation</topic><topic>Interleukins</topic><topic>Lungs</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Parenchyma</topic><topic>Phenols (Class of compounds)</topic><topic>Polyethylene</topic><topic>Polyethylene oxide</topic><topic>Polyethylenes</topic><topic>Pulmonary Fibrosis - chemically induced</topic><topic>Pulmonary Fibrosis - drug therapy</topic><topic>Receptors</topic><topic>Spiperone</topic><topic>Spiperone - therapeutic use</topic><topic>Testes</topic><topic>Therapy</topic><topic>Transforming growth factor</topic><topic>Transforming growth factors</topic><topic>Tumor necrosis factor</topic><topic>Tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Skurikhin, Evgenii Germanovich</creatorcontrib><creatorcontrib>Pershina, Olga Victorovna</creatorcontrib><creatorcontrib>Reztsova, Alena Mikhaylovna</creatorcontrib><creatorcontrib>Ermakova, Natalia Nikolaevna</creatorcontrib><creatorcontrib>Khmelevskaya, Ekaterina Sergeevna</creatorcontrib><creatorcontrib>Krupin, Vycheslav Andreevich</creatorcontrib><creatorcontrib>Stepanova, Inna Ernestovna</creatorcontrib><creatorcontrib>Artamonov, Andrew Vladimirovich</creatorcontrib><creatorcontrib>Bekarev, Andrew Alexandrovich</creatorcontrib><creatorcontrib>Madonov, Pavel Gennadjevich</creatorcontrib><creatorcontrib>Dygai, Alexander Mikhaylovich</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skurikhin, Evgenii Germanovich</au><au>Pershina, Olga Victorovna</au><au>Reztsova, Alena Mikhaylovna</au><au>Ermakova, Natalia Nikolaevna</au><au>Khmelevskaya, Ekaterina Sergeevna</au><au>Krupin, Vycheslav Andreevich</au><au>Stepanova, Inna Ernestovna</au><au>Artamonov, Andrew Vladimirovich</au><au>Bekarev, Andrew Alexandrovich</au><au>Madonov, Pavel Gennadjevich</au><au>Dygai, Alexander Mikhaylovich</au><au>Shi, Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-04-30</date><risdate>2015</risdate><volume>10</volume><issue>4</issue><spage>e0125065</spage><pages>e0125065-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Hyaluronidases are groups of enzymes that degrade hyaluronic acid (HA). To stop enzymatic hydrolysis we modified testicular hyaluronidase (HYAL) by activated polyethylene oxide with the help of electron-beam synthesis. As a result we received pegylated hyaluronidase (pegHYAL). Spiperone is a selective D2 dopamine receptor antagonist. It was demonstrated on the model of a single bleomycin damage of alveolar epithelium that during the inflammatory phase monotherapy by pegHYAL or spiperone reduced the populations of hematopoietic stem /progenitor cells in the lung parenchyma. PegHYAL also reduced the levels of transforming growth factor (TGF)-β, interleukin (IL)-1β, tumor necrosis factor (TNF)-α in the serum and lungs, while spiperone reduced the level of the serum IL-1β. Polytherapy by spiperone and pegHYAL caused the increase of the quantity of hematopoietic stem/ progenitor cells in the lungs. Such an influx of blood cell precursors was observed on the background of considerable fall level of TGF-β and the increase level of TNF-α in the serum and lungs. These results show pegHYAL reduced the bleomycin-induced fibrosis reaction (production and accumulation of collagen) in the lung parenchyma. This effect was observed at a single and repetitive bleomycin damage of alveolar epithelium, the antifibrotic activity of pegHYAL surpassing the activity of testicular HYAL. The antifibrotic effect of pegHYAL is enhanced by an additional instillation of spiperone. Therapy by pegHYAL causes the flow of CD31‒ CD34‒ CD45‒ CD44+ CD73+ CD90+ CD106+-cells into the fibrous lungs. These cells are incapable of differentiating into fibroblast cells. Spiperone instillation separately or together with pegHYAL reduced the MSC-like cells considerably. These data enable us to assume, that pegHYAL is a new and promising instrument both for preventive and therapy of toxic pneumofibrosis. The blockage of D2 dopamine receptors with the following change of hyaluronan matrix can be considered as a new strategy in treatment of pneumofibrosis.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25927611</pmid><doi>10.1371/journal.pone.0125065</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2015-04, Vol.10 (4), p.e0125065
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1677376614
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS) Journals Open Access; PubMed Central; Free Full-Text Journals in Chemistry
subjects Alveoli
Analysis
Animals
Bleomycin
Bleomycin - toxicity
Blockage
Blood cells
Bone morphogenetic proteins
CD34 antigen
CD44 antigen
CD45 antigen
CD73 antigen
CD90 antigen
Cells (biology)
Collagen
Dopamine
Dopamine Antagonists - therapeutic use
Dopamine D2 receptors
Dopamine receptors
Electron beams
Enzyme-Linked Immunosorbent Assay
Enzymes
Epithelium
Fibrosis
Flow Cytometry
Hematopoietic stem cells
Hyaluronic acid
Hyaluronoglucosaminidase - chemistry
Hyaluronoglucosaminidase - therapeutic use
IL-1β
Inflammation
Interleukins
Lungs
Male
Mice
Mice, Inbred C57BL
Parenchyma
Phenols (Class of compounds)
Polyethylene
Polyethylene oxide
Polyethylenes
Pulmonary Fibrosis - chemically induced
Pulmonary Fibrosis - drug therapy
Receptors
Spiperone
Spiperone - therapeutic use
Testes
Therapy
Transforming growth factor
Transforming growth factors
Tumor necrosis factor
Tumor necrosis factor-α
title Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T12%3A42%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20of%20bleomycin-induced%20lung%20fibrosis%20by%20pegylated%20hyaluronidase%20and%20dopamine%20receptor%20antagonist%20in%20mice&rft.jtitle=PloS%20one&rft.au=Skurikhin,%20Evgenii%20Germanovich&rft.date=2015-04-30&rft.volume=10&rft.issue=4&rft.spage=e0125065&rft.pages=e0125065-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0125065&rft_dat=%3Cgale_plos_%3EA419036039%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1677376614&rft_id=info:pmid/25927611&rft_galeid=A419036039&rft_doaj_id=oai_doaj_org_article_2de52e867ebe46538cc1bffb693cb2ea&rfr_iscdi=true